NELLIE GOODIN: Open Payments
NPI 1336724376 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 17 payments from 7 companies in 2025. Trend: 2023 $1,334 · 2024 $813 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $130 |
| Merck Sharp & Dohme LLC | 5 | $82 |
| Boston Scientific Corporation | 2 | $64 |
| Novo Nordisk Inc | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: LEQVIO, VERQUVO, LATITUDE Communicator Power Supply, ELIQUIS, Wegovy, WATCHMAN FLX, JARDIANCE.
Industry payments across WA — which companies pay providers there.
